Propafenone Hydrochloride

盐酸普罗帕酮

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePropafenone Hydrochloride
Drug Alias Name丙胺苯丙酮Propafenona普鲁帕酮PropafenonumRythmol SR +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type V alpha subunit blockersVoltage-gated potassium channel subunit Kv11.1 blockers
TargetsSodium channel protein type V alpha subunitVoltage-gated potassium channel subunit Kv11.1
Therapy Area/IndicationsAtrial FibrillationArrhythmias, Cardiac
Global Approved IndicationsArrhythmias, Cardiac
Approved Indications in ChinaArrhythmias, Cardiac
Original Approved Country/TerritoryN/A
Original Approved Date1979/01/01
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesBgp Pharma UlcAccord Healthcare Ltd
Inactive CompaniesGlaxosmithkline PlcGlaxosmithkline LlcVanderbilt University
Active IndicationsArrhythmias, Cardiac
Inactive IndicationsAtrial Fibrillation

Other Information

ATC CodeC01BC03
Related LinksWikipediaDrugBankKEGG